Treatment of Stage IV Non–Small Cell Lung Cancer with Pembrolizumab in Combination with Platinum-Based Doublet Chemotherapy in Vietnam

Treatment of Stage IV Non–Small Cell Lung Cancer with Pembrolizumab in Combination with Platinum-Based Doublet Chemotherapy in Vietnam

Introduction: Lung cancer has been one of the most prevalent cancers worldwide in recent decades. According to the findings of the KEYNOTE-407 (2018) study on patients with stage IV squamous cell lung cancer, the combination of pembrolizumab and chemotherapy in the first-line treatment prolongs over...

Full description

Bibliographic Details
Main Authors: Khanh Toan Nguyen, To Ta Van
Format: Article
Language:English
Published: Innovative Healthcare Institute 2023-08-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
non–small-cell lung cancer
immunotherapy
pembrolizumab
Online Access:https://jipo.org/doi/pdf/10.36401/JIPO-23-12

Similar Items

Similar Items